SARA SPRINGER: Open Payments
NPI 1104186345 · OLD MONROE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 32 payments from 16 companies in 2025. Trend: 2023 $333 · 2024 $322 · 2025 $876
Food & beverage: $871Education: $6
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $134 |
| Vantive US Healthcare LLC | 1 | $117 |
| Novo Nordisk Inc | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Amgen Inc. | 3 | $67 |
| Travere Therapeutics, Inc. | 4 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: SYMPLICITY G3, Renal - PD, Ozempic, FARXIGA, TAVNEOS, JYNARQUE, BENLYSTA, Kerendia.
Industry payments across MO — which companies pay providers there.
